The Recall Desk
ModerateFDA (Devices)·Z-3173-2026·Announced 2026-09-23

Straumann Recalls GM Helix Implants Due to Packaging Dimension Discrepancy

Straumann USA LLC is recalling 216 GM Helix Implants because the packaging identification does not match the actual implant dimensions.

What this means for you

Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.

Our severity reasoning: The recall is classified as FDA Class II and involves a labeling/packaging discrepancy without reported injuries or illnesses, fitting the criteria for a moderate severity voluntary precautionary recall.

Plain-English summary

Straumann USA LLC is voluntarily recalling 216 units of GM Helix Implants, Reference 109.984, Lot VZPF4. The recall was initiated because there is a discrepancy between the product identification on the packaging and the actual dimensions of the implant contained inside.

The affected products were distributed nationwide in the United States, specifically in the states of Alabama, Arizona, California, Colorado, Florida, Georgia, Illinois, Kansas, Louisiana, Massachusetts, Michigan, Missouri, North Carolina, New Jersey, Nevada, New York, Ohio, Oklahoma, Oregon, Pennsylvania, South Carolina, Texas, Virginia, and Wisconsin.

Consumers and healthcare providers should stop using the affected implants and contact Straumann USA LLC for further instructions or a replacement. The recall is classified as Class II by the FDA.

The recalled product

Product
GM Helix Implant, REF: 109.984;
Manufacturer
Straumann USA LLC
Affected units
216

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (3)

  • REF: 109.984
  • UDI: (01)7899878024552(11)251122(17)301121(10)VZPF4
  • Lot: VZPF4

Distribution

Distributed nationwide across the United States.

The notice also names 24 states specifically:

Similar recalls